Outcome of Cervical Cancer in Iran According to Tumor Histology, Stage of Disease and Therapy

Cancer of cervix, 2nd common cancer of women, is the leading cause of cancer death in developing countries (Magne et al ., 2008; Spensley et al., 2009). In Iran, it’s the 2nd common gynecologic cancer following breast cancer and 2nd common cause of cancer death following ovarian cancer (Mousavi et al., 2008; Karimi et al., 2009). Multiple risk factors such as marriage in young age, pregnancy at youth, numbers of sexual partners, multi parity, smoking, routine screening tests, etc predispose women to cancer of cervix (Karimi et al., 2010). Prognosis and 3-year survival rate of cervical cancer fluctuate in range of 70% to 93%. Many factors such as clinical stage, pathology, pelvic and Paraaortic lymph nodes involvement, vagina and parameter involvement, Hb level before chemotherapy, etc influence survival of cervical cancer cases (Behtash et al., 2009). Outcome of patients like survival and toxicity related to therapy are important factors to be considered (Spensley et al., 2009). The aim of this study was to measure survival of treated cases of cervical cancer from 2002 to 2009 according to pathology, stage of disease, lymph nodes involvement and type of therapy.